tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARVN Stock Latest News

Arvinas announces retirement of CEO John Houston
The FlyArvinas announces retirement of CEO John Houston
18d ago
ARVN
Arvinas Elects New Directors and Ratifies Auditor
PremiumCompany Announcements
Arvinas Elects New Directors and Ratifies Auditor
27d ago
8K
ARVN
Arvinas Unveils Promising ARV-393 Data at EHA Congress
PremiumCompany Announcements
Arvinas Unveils Promising ARV-393 Data at EHA Congress
1M ago
8K
ARVN
Arvinas presents preclinical data from studies of ARV-393
PremiumThe Fly
Arvinas presents preclinical data from studies of ARV-393
1M ago
ARVN
Arvinas R&D President Ian Taylor Resigns
PremiumCompany Announcements
Arvinas R&D President Ian Taylor Resigns
2M ago
8K
ARVN
Arvinas and Pfizer Submit New Drug Application
PremiumCompany AnnouncementsArvinas and Pfizer Submit New Drug Application
2M ago
8K
ARVN
Arvinas announces submission of NDA to FDA for vepdegestrant
Premium
The Fly
Arvinas announces submission of NDA to FDA for vepdegestrant
2M ago
PFE
ARVN
Positive Buy Rating for Arvinas Holding Company Driven by Promising VERITAC-2 Trial Results and Strategic Partnership with Pfizer
Premium
Ratings
Positive Buy Rating for Arvinas Holding Company Driven by Promising VERITAC-2 Trial Results and Strategic Partnership with Pfizer
2M ago
ARVN
Promising Phase 3 Results and Strategic Partnerships Drive Buy Rating for Arvinas
PremiumRatings
Promising Phase 3 Results and Strategic Partnerships Drive Buy Rating for Arvinas
2M ago
ARVN
Arvinas-Pfizer partnership dynamics may shift, says H.C. Wainwright
PremiumThe Fly
Arvinas-Pfizer partnership dynamics may shift, says H.C. Wainwright
2M ago
PFE
ARVN
Buy Rating Justified by Arvinas Holding’s Promising Early-Stage Pipeline Despite Modest Trial Results
PremiumRatings
Buy Rating Justified by Arvinas Holding’s Promising Early-Stage Pipeline Despite Modest Trial Results
2M ago
ARVN
Arvinas and Pfizer Announce Phase 3 Trial Results
PremiumCompany Announcements
Arvinas and Pfizer Announce Phase 3 Trial Results
2M ago
8K
ARVN
Hold Rating on Arvinas Holding Amid Uncertainties in Vepdegestrant’s Market Potential
PremiumRatingsHold Rating on Arvinas Holding Amid Uncertainties in Vepdegestrant’s Market Potential
2M ago
ARVN
Arvinas downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Arvinas downgraded to Market Perform from Outperform at Leerink
2M ago
ARVN
Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance
Premium
The Fly
Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance
2M ago
PFE
ARVN
Arvinas price target lowered to $21 from $74 at UBS
PremiumThe Fly
Arvinas price target lowered to $21 from $74 at UBS
2M ago
ARVN
Becton Dickinson, Spotify, Arvinas, Twilio, Lumen: Trending by Analysts
PremiumWeekend Updates
Becton Dickinson, Spotify, Arvinas, Twilio, Lumen: Trending by Analysts
3M ago
BDX
ARVN
Arvinas price target lowered to $9.50 from $10 at Citi
PremiumThe Fly
Arvinas price target lowered to $9.50 from $10 at Citi
3M ago
ARVN
Strategic Reprioritization and Future Potential Drive Buy Rating for Arvinas Holding Company
PremiumRatings
Strategic Reprioritization and Future Potential Drive Buy Rating for Arvinas Holding Company
3M ago
ARVN
Arvinas downgraded to Hold from Buy at Truist
PremiumThe FlyArvinas downgraded to Hold from Buy at Truist
3M ago
ARVN
Arvinas Earnings Call: Clinical Progress and Strategic Shifts
Premium
Company Announcements
Arvinas Earnings Call: Clinical Progress and Strategic Shifts
3M ago
ARVN
Arvinas price target lowered to $10 from $20 at BMO Capital
Premium
The Fly
Arvinas price target lowered to $10 from $20 at BMO Capital
3M ago
ARVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >